ATLANTA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The Tiffany Henyard Scholarship for Entrepreneurs is now accepting applications from ambitious undergraduate students across the United States who possess a passion for innovation and a clear vision for their business futures. This initiative, founded by prominent public figure Tiffany Henyard, aims to provide financial support and recognition…
Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Marine Inertial Navigation Systems Market Report 2026" has been added to ResearchAndMarkets.com's offering. The marine inertial navigation systems market has experienced significant growth, with projections indicating a rise from $9.44 billion in 2025 to $10.02 billion in 2026 at a 6.1% compound annual growth rate (CAGR). This…
Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Vietnam Data Center Market - Investment Analysis & Growth Opportunities 2026-2031" report has been added to ResearchAndMarkets.com's offering. The Vietnam Data Center Market was valued at USD 1.04 Billion in 2025, and is projected to reach USD 3.18 Billion by 2031, rising at a CAGR of 20.48%.
14 January 2026. Stockholm: Bitwise today announces the listing of seven of its crypto ETPs on Nasdaq Stockholm, marking a strategic expansion in the Nordic markets. The listings give Swedish investors access to exchange-listed crypto exposure through regulated products denominated in Swedish kronor (SEK). The company has appointed Marco Poblete as Regional Director for the…
LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Evolutionary biologist Dr. Toby Kiers is receiving the Tyler Prize for Environmental Achievement, considered the ‘Nobel Prize for Environment’, as her not-for-profit, the Society for the Protection of Underground Networks (SPUN), launches a new program called “Underground Advocates” equipping scientists with legal tools to protect fungal biodiversity, the…
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts public offering of 5,366,726 units. Each unit consists of one common share (or…